Rare diseases
Investigational molecules
Locations
10 Rue De La Grange Bateliere, 75009 Paris, France
The portfolio is centered on non-small cell lung cancer across advanced, metastatic, and resected settings, with particular attention to molecularly defined disease.
Research also includes post-treatment disease control and adjuvant strategies for patients with resected early-stage disease.
Intergroupe Francophone De Cancerologie Thoracique runs clinical trials in conditions such as Non-small cell lung cancer stage IV, Non-small cell lung cancer, Non-small cell lung cancer stage IIIB, Non-small cell lung cancer stage III, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceFranceFranceFranceFranceFranceFranceFranceFranceFranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
